| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.877 | 0.004 | 0.883 | Caspase 9 stimulant | 0.883 0.004 CID_154699820 | CID_154699820 | |
| 0.854 | 0.004 | 0.854 | 12-Lipoxygenase inhibitor | |||
| 0.821 | 0.005 | 0.821 | 15-Lipoxygenase inhibitor | |||
| 0.751 | 0.025 | 0.932 | Alpha-glucosidase inhibitor | 0.932 0.005 CID_154699820 | CID_154699820 | |
| 0.737 | 0.025 | 0.764 | Apoptosis agonist | 0.764 0.021 CID_154699820 | CID_154699820 | |
| 0.698 | 0.005 | 0.845 | Histamine release inhibitor | 0.845 0.003 CID_154699820 | CID_154699820 | |
| 0.687 | 0.006 | 0.687 | Caspase 3 stimulant | 0.604 0.01 CID_154699820 | ||
| 0.686 | 0.013 | 0.686 | Prostaglandin dehydrogenase inhibitor | |||
| 0.639 | 0.005 | 0.639 | MAO inhibitor | |||
| 0.629 | 0.004 | 0.629 | Pyruvate kinase inhibitor | 0.369 0.028 CID_154699820 | ||
| 0.628 | 0.007 | 0.748 | Free radical scavenger | 0.748 0.004 CID_154699820 | CID_154699820 | |
| 0.632 | 0.013 | 0.632 | Aryl hydrocarbon receptor agonist | 0.175 0.117 CID_154699820 | ||
| 0.619 | 0.01 | 0.776 | Antioxidant | 0.776 0.005 CID_154699820 | CID_154699820 | |
| 0.605 | 0.009 | 0.605 | Lipoxygenase inhibitor | |||
| 0.59 | 0.005 | 0.59 | Topoisomerase II inhibitor | 0.567 0.005 CID_154699820 | ||
| 0.569 | 0.009 | 0.603 | Hypoxia-inducible factor 1 alpha inhibitor | 0.603 0.007 CID_154699820 | CID_154699820 | |
| 0.59 | 0.032 | 0.814 | Transcription factor NF kappa B inhibitor | 0.814 0.012 CID_154699820 | CID_154699820 | |
| 0.548 | 0.005 | 0.548 | MAO A inhibitor | |||
| 0.584 | 0.063 | 0.584 | DNA polymerase beta inhibitor | |||
| 0.522 | 0.004 | 0.522 | NADPH oxidase inhibitor | 0.507 0.004 CID_154699820 | ||
| 0.521 | 0.004 | 0.546 | Neurotrophic factor enhancer | 0.546 0.003 CID_154699820 | CID_154699820 | |
| 0.529 | 0.024 | 0.631 | 5 Hydroxytryptamine release inhibitor | 0.631 0.008 CID_154699820 | CID_154699820 | |
| 0.566 | 0.065 | 0.566 | DNA directed DNA polymerase inhibitor | 0.308 0.158 CID_154699820 | ||
| 0.499 | 0.007 | 0.715 | Melanin inhibitor | 0.715 0.003 CID_154699820 | CID_154699820 | |
| 0.501 | 0.013 | 0.501 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.207 0.088 CID_154699820 | ||
| 0.49 | 0.005 | 0.49 | MAO B inhibitor | |||
| 0.47 | 0.02 | 0.839 | Vasodilator, coronary | 0.839 0.003 CID_154699820 | CID_154699820 | |
| 0.479 | 0.031 | 0.479 | 5 Hydroxytryptamine release stimulant | 0.388 0.048 CID_154699820 | ||
| 0.46 | 0.018 | 0.46 | Dyrk kinase inhibitor | 0.173 0.115 CID_154699820 | ||
| 0.446 | 0.004 | 0.446 | Topoisomerase II alpha inhibitor | 0.41 0.005 CID_154699820 | ||
| 0.443 | 0.015 | 0.443 | Peroxidase inhibitor | |||
| 0.429 | 0.012 | 0.429 | Dual specificity phosphatase inhibitor | |||
| 0.447 | 0.031 | 0.67 | Spasmolytic | 0.67 0.008 CID_154699820 | CID_154699820 | |
| 0.415 | 0.007 | 0.415 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.29 0.027 CID_154699820 | ||
| 0.428 | 0.023 | 0.589 | DNA damaging | 0.589 0.009 CID_154699820 | CID_154699820 | |
| 0.416 | 0.012 | 0.416 | Dual specificity phosphatase 3 inhibitor | |||
| 0.416 | 0.016 | 0.416 | RNA-directed DNA polymerase inhibitor | 0.301 0.031 CID_154699820 | ||
| 0.417 | 0.034 | 0.417 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.406 | 0.024 | 0.406 | Amyloid beta aggregation inhibitor | 0.355 0.033 CID_154699820 | ||
| 0.391 | 0.014 | 0.613 | Hepatoprotectant | 0.613 0.004 CID_154699820 | CID_154699820 | |
| 0.382 | 0.01 | 0.726 | Amylase inhibitor | 0.726 0.003 CID_154699820 | CID_154699820 | |
| 0.378 | 0.01 | 0.483 | Protein kinase stimulant | 0.483 0.004 CID_154699820 | CID_154699820 | |
| 0.385 | 0.018 | 0.385 | P-glycoprotein inhibitor | 0.254 0.04 CID_154699820 | ||
| 0.371 | 0.006 | 0.41 | Topoisomerase I inhibitor | 0.41 0.005 CID_154699820 | CID_154699820 | |
| 0.388 | 0.025 | 0.479 | Vasodilator | 0.479 0.014 CID_154699820 | CID_154699820 | |
| 0.365 | 0.004 | 0.365 | Carbonic anhydrase VI inhibitor | 0.166 0.018 CID_154699820 | ||
| 0.367 | 0.007 | 0.367 | Heat shock protein 90 alpha antagonist | |||
| 0.364 | 0.005 | 0.364 | Heat shock protein 90 antagonist | 0.135 0.091 CID_154699820 | ||
| 0.395 | 0.04 | 0.59 | Apoptosis antagonist | 0.59 0.011 CID_154699820 | CID_154699820 | |
| 0.361 | 0.005 | 0.361 | Interleukin 4 antagonist | 0.215 0.019 CID_154699820 | ||
| 0.362 | 0.014 | 0.362 | Tubulin antagonist | 0.113 0.087 CID_154699820 | ||
| 0.401 | 0.055 | 0.401 | Thyroid hormone antagonist | |||
| 0.343 | 0.004 | 0.343 | Macrophage migration inhibitory factor inhibitor | |||
| 0.368 | 0.029 | 0.556 | Nitric oxide antagonist | 0.556 0.012 CID_154699820 | CID_154699820 | |
| 0.335 | 0.005 | 0.335 | Telomerase inhibitor | 0.079 0.045 CID_154699820 | ||
| 0.336 | 0.007 | 0.336 | CDC-like kinase 1 inhibitor | 0.149 0.071 CID_154699820 | ||
| 0.386 | 0.057 | 0.386 | Thyroid hormone beta antagonist | |||
| 0.359 | 0.036 | 0.694 | Hypoglycemic | 0.694 0.005 CID_154699820 | CID_154699820 | |
| 0.354 | 0.033 | 0.354 | Transcription factor STAT inhibitor | |||
| 0.375 | 0.054 | 0.375 | Streptokinase A inhibitor | |||
| 0.422 | 0.101 | 0.422 | Transcription factor inhibitor | |||
| 0.326 | 0.006 | 0.524 | Xanthine oxidase inhibitor | 0.524 0.004 CID_154699820 | CID_154699820 | |
| 0.333 | 0.015 | 0.437 | Lipid peroxidase inhibitor | 0.437 0.008 CID_154699820 | CID_154699820 | |
| 0.322 | 0.015 | 0.451 | NOS3 expression enhancer | 0.451 0.006 CID_154699820 | CID_154699820 | |
| 0.311 | 0.012 | 0.311 | Acetylcholinesterase inhibitor | 0.158 0.05 CID_154699820 | ||
| 0.374 | 0.089 | 0.69 | Antibacterial | 0.69 0.009 CID_154699820 | CID_154699820 | |
| 0.29 | 0.01 | 0.29 | Cystathionine beta-synthase inhibitor | 0.257 0.014 CID_154699820 | ||
| 0.355 | 0.083 | 0.355 | GABA C receptor rho-3 antagonist | |||
| 0.287 | 0.019 | 0.613 | Monophenol monooxygenase inhibitor | 0.613 0.005 CID_154699820 | CID_154699820 | |
| 0.271 | 0.008 | 0.271 | Breast cancer-resistant protein inhibitor | |||
| 0.265 | 0.004 | 0.265 | Multidrug resistance-associated protein 1 inhibitor | 0.214 0.008 CID_154699820 | ||
| 0.301 | 0.043 | 0.301 | Antimitotic | |||
| 0.259 | 0.005 | 0.259 | Creatine kinase inhibitor | |||
| 0.274 | 0.025 | 0.274 | Protein-tyrosine phosphatase inhibitor | 0.213 0.042 CID_154699820 | ||
| 0.272 | 0.025 | 0.272 | Amyloid beta precursor protein antagonist | |||
| 0.248 | 0.006 | 0.248 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.243 | 0.004 | 0.243 | CDC-like kinase 3 inhibitor | 0.139 0.025 CID_154699820 | ||
| 0.244 | 0.01 | 0.244 | Carbonic anhydrase III inhibitor | 0.124 0.041 CID_154699820 | ||
| 0.25 | 0.021 | 0.25 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.266 | 0.037 | 0.513 | Non-steroidal antiinflammatory agent | 0.513 0.006 CID_154699820 | CID_154699820 | |
| 0.23 | 0.004 | 0.23 | Xanthine dehydrogenase inhibitor | 0.097 0.016 CID_154699820 | ||
| 0.247 | 0.029 | 0.247 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.235 | 0.018 | 0.243 | DNA intercalator | 0.243 0.017 CID_154699820 | CID_154699820 | |
| 0.22 | 0.004 | 0.22 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.165 0.005 CID_154699820 | ||
| 0.233 | 0.017 | 0.233 | Butyrylcholinesterase inhibitor | |||
| 0.223 | 0.008 | 0.223 | HIV-1 integrase (3'-Processing) inhibitor | 0.103 0.025 CID_154699820 | ||
| 0.232 | 0.019 | 0.405 | ATPase inhibitor | 0.405 0.004 CID_154699820 | CID_154699820 | |
| 0.216 | 0.005 | 0.216 | Heat shock protein 70 antagonist | 0.206 0.005 CID_154699820 | ||
| 0.224 | 0.02 | 0.224 | 5-Lipoxygenase inhibitor | |||
| 0.212 | 0.009 | 0.212 | HIV-1 integrase (Strand Transfer) inhibitor | 0.092 0.026 CID_154699820 | ||
| 0.214 | 0.012 | 0.267 | Carbonic anhydrase XIII inhibitor | 0.267 0.008 CID_154699820 | CID_154699820 | |
| 0.234 | 0.033 | 0.234 | Cholinergic | |||
| 0.227 | 0.026 | 0.227 | Cyclooxygenase 1 inhibitor | 0.172 0.047 CID_154699820 | ||
| 0.205 | 0.006 | 0.205 | Alpha tubulin antagonist | |||
| 0.206 | 0.009 | 0.206 | Papain-like protease (SARS coronavirus) inhibitor | 0.132 0.057 CID_154699820 | ||
| 0.201 | 0.006 | 0.201 | Phosphodiesterase V inhibitor | 0.077 0.044 CID_154699820 | ||
| 0.202 | 0.006 | 0.202 | CDC25A inhibitor | 0.089 0.035 CID_154699820 | ||
| 0.202 | 0.006 | 0.202 | DOPA decarboxylase inhibitor | |||
| 0.245 | 0.051 | 0.419 | Platelet adhesion inhibitor | 0.419 0.01 CID_154699820 | CID_154699820 | |
| 0.198 | 0.005 | 0.198 | CD45 antagonist | |||
| 0.2 | 0.006 | 0.2 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.14 0.017 CID_154699820 | ||
| 0.2 | 0.008 | 0.2 | CYP2A6 inhibitor | |||
| 0.218 | 0.027 | 0.31 | Alkaline phosphatase inhibitor | 0.31 0.011 CID_154699820 | CID_154699820 | |
| 0.234 | 0.045 | 0.281 | Nitric-oxide synthase stimulant | 0.281 0.017 CID_154699820 | CID_154699820 | |
| 0.23 | 0.043 | 0.23 | Mcl-1 antagonist | |||
| 0.217 | 0.035 | 0.217 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.184 | 0.004 | 0.184 | Heat shock protein 90 beta antagonist | |||
| 0.184 | 0.006 | 0.184 | Myeloperoxidase inhibitor | |||
| 0.194 | 0.02 | 0.194 | Carbonic anhydrase XV inhibitor | |||
| 0.234 | 0.062 | 0.234 | Clk dual-specificity kinase inhibitor | |||
| 0.223 | 0.052 | 0.223 | Insulin sensitizer | 0.21 0.064 CID_154699820 | ||
| 0.177 | 0.008 | 0.177 | Phosphodiesterase 5A inhibitor | 0.067 0.053 CID_154699820 | ||
| 0.25 | 0.081 | 0.25 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.282 | 0.113 | 0.282 | Thioredoxin glutathione reductase inhibitor | |||
| 0.199 | 0.031 | 0.209 | Mannose-6-phosphate isomerase inhibitor | 0.209 0.026 CID_154699820 | CID_154699820 | |
| 0.24 | 0.074 | 0.416 | DNA synthesis inhibitor | 0.416 0.02 CID_154699820 | CID_154699820 | |
| 0.178 | 0.014 | 0.385 | DNA repair enzyme inhibitor | 0.385 0.003 CID_154699820 | CID_154699820 | |
| 0.274 | 0.111 | 0.274 | Vasodilator, peripheral | 0.214 0.16 CID_154699820 | ||
| 0.197 | 0.036 | 0.197 | Bone formation stimulant | 0.149 0.059 CID_154699820 | ||
| 0.32 | 0.159 | 0.32 | MAP kinase 1 inhibitor | |||
| 0.177 | 0.017 | 0.18 | Uric acid excretion stimulant | 0.18 0.016 CID_154699820 | CID_154699820 | |
| 0.219 | 0.058 | 0.219 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.201 | 0.042 | 0.206 | Cyclooxygenase inhibitor | 0.206 0.04 CID_154699820 | CID_154699820 | |
| 0.245 | 0.087 | 0.245 | Transcription factor STAT3 inhibitor | |||
| 0.156 | 0.003 | 0.156 | Glutamate (mGluR7) antagonist | 0.069 0.044 CID_154699820 | ||
| 0.155 | 0.009 | 0.169 | T cell inhibitor | 0.169 0.009 CID_154699820 | CID_154699820 | |
| 0.159 | 0.014 | 0.159 | Estrogen receptor beta antagonist | |||
| 0.23 | 0.085 | 0.484 | Tumour necrosis factor alpha release inhibitor | 0.484 0.015 CID_154699820 | CID_154699820 | |
| 0.153 | 0.009 | 0.153 | Histone deacetylase stimulant | 0.14 0.011 CID_154699820 | ||
| 0.153 | 0.009 | 0.153 | Histone deacetylase SIRT1 stimulant | 0.14 0.011 CID_154699820 | ||
| 0.162 | 0.018 | 0.162 | Urease inhibitor | |||
| 0.187 | 0.043 | 0.27 | Insulin secretagoues | 0.27 0.016 CID_154699820 | CID_154699820 | |
| 0.174 | 0.031 | 0.455 | Cyclooxygenase 3 inhibitor | 0.455 0.004 CID_154699820 | CID_154699820 | |
| 0.178 | 0.038 | 0.186 | Cyclooxygenase 2 inhibitor | 0.186 0.035 CID_154699820 | CID_154699820 | |
| 0.147 | 0.007 | 0.147 | CDC25B inhibitor | 0.061 0.048 CID_154699820 | ||
| 0.259 | 0.12 | 0.692 | Antithrombotic | 0.692 0.009 CID_154699820 | CID_154699820 | |
| 0.143 | 0.004 | 0.143 | Endothelin receptor antagonist | 0.025 0.023 CID_154699820 | ||
| 0.155 | 0.018 | 0.155 | Electron transport complex I inhibitor | |||
| 0.192 | 0.057 | 0.192 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.226 | 0.092 | 0.226 | Superoxide dismutase inhibitor | |||
| 0.145 | 0.011 | 0.182 | Aldose reductase inhibitor | 0.182 0.008 CID_154699820 | CID_154699820 | |
| 0.155 | 0.021 | 0.155 | Estrogen antagonist | |||
| 0.201 | 0.068 | 0.276 | DNA methyltransferase I inhibitor | 0.276 0.036 CID_154699820 | CID_154699820 | |
| 0.143 | 0.012 | 0.143 | Phosphodiesterase 11A inhibitor | |||
| 0.143 | 0.012 | 0.143 | Phosphodiesterase XI inhibitor | |||
| 0.217 | 0.088 | 0.411 | Antiamyloidogenic | 0.411 0.027 CID_154699820 | CID_154699820 | |
| 0.134 | 0.006 | 0.134 | Protease activated receptor antagonist | 0.062 0.045 CID_154699820 | ||
| 0.137 | 0.014 | 0.137 | Beta tubulin antagonist | |||
| 0.148 | 0.026 | 0.455 | Beta glucuronidase inhibitor | 0.455 0.004 CID_154699820 | CID_154699820 | |
| 0.134 | 0.012 | 0.134 | mTOR complex 2 inhibitor | |||
| 0.15 | 0.028 | 0.322 | AMP-activated protein kinase stimulant | 0.322 0.005 CID_154699820 | CID_154699820 | |
| 0.181 | 0.06 | 0.181 | Phospholipase C inhibitor | 0.154 0.099 CID_154699820 | ||
| 0.201 | 0.079 | 0.25 | Psychostimulant | 0.25 0.059 CID_154699820 | CID_154699820 | |
| 0.135 | 0.015 | 0.135 | Aromatase inhibitor | |||
| 0.134 | 0.015 | 0.209 | Phosphodiesterase 6D inhibitor | 0.209 0.004 CID_154699820 | CID_154699820 | |
| 0.161 | 0.042 | 0.161 | Protein-tyrosine phosphatase 1B inhibitor | 0.16 0.042 CID_154699820 | ||
| 0.162 | 0.045 | 0.162 | Adenylate cyclase stimulant | |||
| 0.129 | 0.014 | 0.129 | Thioredoxin reductase inhibitor | 0.08 0.063 CID_154699820 | ||
| 0.192 | 0.077 | 0.192 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.151 | 0.041 | 0.151 | Protein kinase (CK2) alpha inhibitor | |||
| 0.114 | 0.004 | 0.114 | Endothelin B receptor antagonist | 0.021 0.012 CID_154699820 | ||
| 0.178 | 0.07 | 0.178 | Succinate dehydrogenase inhibitor | |||
| 0.14 | 0.032 | 0.14 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.12 | 0.013 | 0.12 | D-Ala-D-Ala ligase inhibitor | |||
| 0.252 | 0.146 | 0.491 | Immunosuppressant | 0.491 0.035 CID_154699820 | CID_154699820 | |
| 0.188 | 0.081 | 0.188 | Anesthetic general | 0.183 0.085 CID_154699820 | ||
| 0.127 | 0.022 | 0.127 | Inducible nitric-oxide synthase inhibitor | |||
| 0.107 | 0.004 | 0.107 | Endothelin A receptor antagonist | |||
| 0.188 | 0.087 | 0.272 | DNA methylase inhibitor | 0.272 0.037 CID_154699820 | CID_154699820 | |
| 0.174 | 0.073 | 0.174 | Tumour necrosis factor antagonist | |||
| 0.137 | 0.04 | 0.203 | Photosensitizer | 0.203 0.012 CID_154699820 | CID_154699820 | |
| 0.122 | 0.025 | 0.122 | Ornithine decarboxylase inhibitor | 0.098 0.046 CID_154699820 | ||
| 0.135 | 0.038 | 0.135 | Transcription factor STAT6 inhibitor | |||
| 0.127 | 0.031 | 0.127 | Calcium antagonist | |||
| 0.104 | 0.009 | 0.104 | Topoisomerase II beta inhibitor | 0.087 0.011 CID_154699820 | ||
| 0.129 | 0.034 | 0.129 | Antineoplastic alkaloid | |||
| 0.117 | 0.022 | 0.139 | ATPase (Vacuolar H+) inhibitor | 0.139 0.01 CID_154699820 | CID_154699820 | |
| 0.103 | 0.01 | 0.103 | Fatty acid synthase inhibitor | 0.053 0.045 CID_154699820 | ||
| 0.097 | 0.005 | 0.097 | Ryanodine receptor antagonist | |||
| 0.111 | 0.019 | 0.111 | HIV-1 integrase inhibitor | |||
| 0.112 | 0.021 | 0.112 | Estrogen receptor alpha antagonist | |||
| 0.106 | 0.017 | 0.165 | Phosphodiesterase VI inhibitor | 0.165 0.005 CID_154699820 | CID_154699820 | |
| 0.113 | 0.024 | 0.113 | Keratolytic | |||
| 0.119 | 0.031 | 0.119 | ABCA1 expression enhancer | |||
| 0.159 | 0.076 | 0.224 | Interleukin 6 antagonist | 0.224 0.03 CID_154699820 | CID_154699820 | |
| 0.169 | 0.086 | 0.169 | CDC-like kinase 4 inhibitor | |||
| 0.095 | 0.015 | 0.095 | Aryl hydrocarbon receptor antagonist | |||
| 0.085 | 0.006 | 0.085 | Adenylate cyclase 1 inhibitor | |||
| 0.104 | 0.027 | 0.104 | Glutamate decarboxylase inhibitor | |||
| 0.144 | 0.067 | 0.144 | Cytokine production inhibitor | |||
| 0.203 | 0.128 | 0.203 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.086 | 0.012 | 0.086 | Carbonic anhydrase VII inhibitor | 0.057 0.021 CID_154699820 | ||
| 0.145 | 0.072 | 0.145 | MAP kinase kinase 4 inhibitor | |||
| 0.143 | 0.071 | 0.143 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.293 | 0.222 | 0.733 | Antiinflammatory | 0.733 0.025 CID_154699820 | CID_154699820 | |
| 0.144 | 0.075 | 0.464 | Hemostatic | 0.464 0.005 CID_154699820 | CID_154699820 | |
| 0.156 | 0.092 | 0.156 | Catenin beta inhibitor | |||
| 0.07 | 0.008 | 0.07 | GABA B receptor antagonist | |||
| 0.092 | 0.032 | 0.092 | Lipase inhibitor | |||
| 0.177 | 0.118 | 0.177 | Aldehyde oxidase inhibitor | |||
| 0.184 | 0.126 | 0.184 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.073 | 0.015 | 0.073 | DNA helicase inhibitor | 0.057 0.033 CID_154699820 | ||
| 0.089 | 0.033 | 0.089 | Cyclin B3 inhibitor | |||
| 0.095 | 0.039 | 0.095 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.114 | 0.06 | 0.114 | Chelator | |||
| 0.109 | 0.056 | 0.109 | Protein kinase (CK2) inhibitor | |||
| 0.138 | 0.085 | 0.138 | Cytidine deaminase inhibitor | |||
| 0.118 | 0.07 | 0.241 | Alkylator | 0.241 0.018 CID_154699820 | CID_154699820 | |
| 0.136 | 0.089 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.131 0.113 CID_154699820 | ||
| 0.085 | 0.04 | 0.085 | GABA aminotransferase inhibitor | 0.08 0.047 CID_154699820 | ||
| 0.063 | 0.019 | 0.063 | Potassium channel Kv1.3 blocker | |||
| 0.061 | 0.017 | 0.069 | Factor III inhibitor | 0.069 0.011 CID_154699820 | CID_154699820 | |
| 0.056 | 0.012 | 0.056 | Phosphodiesterase 6C inhibitor | 0.051 0.02 CID_154699820 | ||
| 0.113 | 0.07 | 0.158 | Microtubule formation inhibitor | 0.158 0.034 CID_154699820 | CID_154699820 | |
| 0.061 | 0.021 | 0.061 | CXC chemokine 1 receptor antagonist | |||
| 0.132 | 0.093 | 0.132 | Thiol protease inhibitor | |||
| 0.063 | 0.025 | 0.09 | Leukotriene B4 antagonist | 0.09 0.013 CID_154699820 | CID_154699820 | |
| 0.053 | 0.015 | 0.053 | Dopamine D5 agonist | |||
| 0.076 | 0.04 | 0.076 | Carbonic anhydrase VA inhibitor | |||
| 0.07 | 0.034 | 0.094 | Neuraminidase inhibitor | 0.094 0.018 CID_154699820 | CID_154699820 | |
| 0.072 | 0.038 | 0.072 | Leukotriene antagonist | |||
| 0.11 | 0.077 | 0.11 | Interleukin 8 antagonist | |||
| 0.085 | 0.054 | 0.222 | Antineoplastic antibiotic | 0.222 0.018 CID_154699820 | CID_154699820 | |
| 0.132 | 0.101 | 0.132 | Sigma receptor agonist | |||
| 0.159 | 0.128 | 0.159 | Histone acetyltransferase inhibitor | |||
| 0.071 | 0.042 | 0.071 | Carbonic anhydrase V inhibitor | |||
| 0.077 | 0.048 | 0.077 | GABA B receptor agonist | |||
| 0.091 | 0.062 | 0.094 | Alcohol dehydrogenase inhibitor | 0.094 0.06 CID_154699820 | CID_154699820 | |
| 0.065 | 0.04 | 0.065 | Transcription factor RelA inhibitor | |||
| 0.056 | 0.032 | 0.057 | Estrogen agonist | 0.057 0.032 CID_154699820 | CID_154699820 | |
| 0.084 | 0.061 | 0.153 | Transcription factor NF kappa B stimulant | 0.153 0.015 CID_154699820 | CID_154699820 | |
| 0.097 | 0.075 | 0.097 | Factor V inhibitor | |||
| 0.132 | 0.11 | 0.132 | Arachidonic acid antagonist | |||
| 0.069 | 0.052 | 0.069 | Histidine decarboxylase inhibitor | |||
| 0.11 | 0.093 | 0.11 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.044 | 0.028 | 0.044 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.04 | 0.025 | 0.04 | Retinoic acid alpha receptor agonist | |||
| 0.036 | 0.023 | 0.036 | Estrogen receptor alpha agonist | |||
| 0.106 | 0.093 | 0.106 | M17 leucyl aminopeptidase inhibitor | |||
| 0.034 | 0.021 | 0.034 | Catechol O-methyltransferase inhibitor | |||
| 0.027 | 0.015 | 0.027 | Dopamine autoreceptor agonist | |||
| 0.106 | 0.095 | 0.106 | Toll-Like receptor 2 antagonist | |||
| 0.022 | 0.012 | 0.022 | Imidazoline I1 receptor antagonist | |||
| 0.063 | 0.054 | 0.063 | Potassium channel large-conductance Ca-activated activator | |||
| 0.026 | 0.018 | 0.109 | Sodium/glucose cotransporter 2 inhibitor | 0.109 0.003 CID_154699820 | CID_154699820 | |
| 0.081 | 0.074 | 0.081 | Potassium channel (Ca-activated) activator | |||
| 0.098 | 0.091 | 0.098 | Activin receptor-like kinase 4 inhibitor | |||
| 0.012 | 0.006 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.124 | 0.118 | 0.124 | Pregnane X receptor agonist | |||
| 0.054 | 0.048 | 0.054 | Leukotriene C antagonist | |||
| 0.057 | 0.053 | 0.057 | Dopamine D1 antagonist | |||
| 0.028 | 0.025 | 0.028 | Phosphodiesterase 6B inhibitor | |||
| 0.184 | 0.18 | 0.387 | Cholesterol antagonist | 0.387 0.052 CID_154699820 | CID_154699820 | |
| 0.022 | 0.02 | 0.022 | Phosphodiesterase 6G inhibitor | |||
| 0.022 | 0.02 | 0.022 | Phosphodiesterase 6H inhibitor | |||
| 0.084 | 0.083 | 0.084 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.021 | 0.02 | 0.021 | Dopamine D1 agonist | |||
| 0.134 | 0.133 | 0.608 | Angiogenesis stimulant | 0.608 0.006 CID_154699820 | CID_154699820 | |
| 0.048 | 0.051 | 0.151 | Heparanase inhibitor | 0.151 0.003 CID_154699820 | CID_154699820 | |
| 0.022 | 0.032 | 0.085 | Sodium/glucose cotransporter inhibitor | 0.085 0.003 CID_154699820 | CID_154699820 | |
| 0.055 | 0.068 | 0.085 | Neuraminidase (influenza) inhibitor | 0.085 0.022 CID_154699820 | CID_154699820 | |
| 0.085 | 0.103 | 0.099 | Mucolytic | 0.099 0.079 CID_154699820 | CID_154699820 | |
| 0.034 | 0.051 | 0.102 | Carbonic anhydrase XII inhibitor | 0.102 0.02 CID_154699820 | CID_154699820 | |
| 0.144 | 0.163 | 0.305 | Cyclic AMP phosphodiesterase inhibitor | 0.305 0.04 CID_154699820 | CID_154699820 | |
| 0.055 | 0.077 | 0.113 | Na+ K+ transporting ATPase inhibitor | 0.113 0.021 CID_154699820 | CID_154699820 | |
| 0.064 | 0.097 | 0.155 | Falcipain 2 inhibitor | 0.155 0.026 CID_154699820 | CID_154699820 | |
| 0.073 | 0.108 | 0.26 | Expectorant | 0.26 0.012 CID_154699820 | CID_154699820 | |
| 0.065 | 0.101 | 0.157 | Falcipain inhibitor | 0.157 0.028 CID_154699820 | CID_154699820 | |
| 0.071 | 0.109 | 0.147 | UDP-glucose 4-epimerase inhibitor | 0.147 0.03 CID_154699820 | CID_154699820 | |
| 0.113 | 0.152 | 0.195 | Interferon gamma antagonist | 0.195 0.042 CID_154699820 | CID_154699820 | |
| 0.015 | 0.054 | 0.055 | Arginase inhibitor | 0.055 0.012 CID_154699820 | CID_154699820 | |
| 0.066 | 0.112 | 0.123 | Triose-phosphate isomerase inhibitor | 0.123 0.03 CID_154699820 | CID_154699820 | |
| 0.082 | 0.134 | 0.152 | Alpha-N-acetylglucosaminidase inhibitor | 0.152 0.054 CID_154699820 | CID_154699820 | |
| 0.034 | 0.093 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.013 CID_154699820 | CID_154699820 | |
| 0.013 | 0.074 | 0.045 | Protein 30S ribosomal subunit inhibitor | 0.045 0.009 CID_154699820 | CID_154699820 | |
| 0.063 | 0.127 | 0.106 | NADH dehydrogenase inhibitor | 0.106 0.038 CID_154699820 | CID_154699820 | |
| 0.065 | 0.13 | 0.11 | Thioredoxin inhibitor | 0.11 0.039 CID_154699820 | CID_154699820 | |
| 0.015 | 0.081 | 0.024 | Vanilloid 2 agonist | 0.024 0.021 CID_154699820 | CID_154699820 | |
| 0.03 | 0.101 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 CID_154699820 | CID_154699820 | |
| 0.032 | 0.121 | 0.069 | Nitric oxide donor | 0.069 0.034 CID_154699820 | CID_154699820 | |
| 0.021 | 0.111 | 0.066 | Mannosidase inhibitor | 0.066 0.013 CID_154699820 | CID_154699820 | |
| 0.085 | 0.178 | 0.247 | Cell wall synthesis inhibitor | 0.247 0.016 CID_154699820 | CID_154699820 | |
| 0.039 | 0.138 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.032 CID_154699820 | CID_154699820 | |
| 0.026 | 0.139 | 0.064 | Phosphofructokinase-1 inhibitor | 0.064 0.053 CID_154699820 | CID_154699820 | |
| 0.023 | 0.142 | 0.043 | Microtubule stabilization | 0.043 0.037 CID_154699820 | CID_154699820 | |
| 0.078 | 0.204 | 0.216 | Diuretic | 0.216 0.039 CID_154699820 | CID_154699820 | |
| 0.098 | 0.225 | 0.302 | Platelet antagonist | 0.302 0.052 CID_154699820 | CID_154699820 | |
| 0.097 | 0.226 | 0.454 | Immunostimulant | 0.454 0.036 CID_154699820 | CID_154699820 | |
| 0.06 | 0.208 | 0.151 | Interleukin 12 antagonist | 0.151 0.012 CID_154699820 | CID_154699820 | |
| 0.101 | 0.264 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.045 CID_154699820 | CID_154699820 | |
| 0.039 | 0.213 | 0.111 | Mediator release inhibitor | 0.111 0.058 CID_154699820 | CID_154699820 | |
| 0.122 | 0.299 | 0.36 | Peptidyltransferase inhibitor | 0.36 0.011 CID_154699820 | CID_154699820 | |
| 0.024 | 0.212 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.073 0.014 CID_154699820 | CID_154699820 | |
| 0.07 | 0.261 | 0.165 | Hexokinase inhibitor | 0.165 0.063 CID_154699820 | CID_154699820 | |
| 0.017 | 0.211 | 0.067 | Antibiotic Aminoglycoside-like | 0.067 0.007 CID_154699820 | CID_154699820 | |
| 0.015 | 0.231 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 CID_154699820 | CID_154699820 | |
| 0.016 | 0.233 | 0.09 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 CID_154699820 | CID_154699820 | |
| 0.034 | 0.278 | 0.058 | Lipocortins synthesis agonist | 0.058 0.04 CID_154699820 | CID_154699820 | |
| 0.045 | 0.295 | 0.144 | Toll-Like receptor 4 antagonist | 0.144 0.025 CID_154699820 | CID_154699820 | |
| 0.05 | 0.348 | 0.242 | Hypolipemic | 0.242 0.071 CID_154699820 | CID_154699820 | |
| 0.032 | 0.343 | 0.277 | Thrombolytic | 0.277 0.028 CID_154699820 | CID_154699820 | |
| 0.103 | 0.469 | 0.7 | Cyclophilin D inhibitor | 0.7 0.014 CID_154699820 | CID_154699820 | |
| 0.009 | 0.398 | 0.305 | Selectin antagonist | 0.305 0.005 CID_154699820 | CID_154699820 | |
| 0.01 | 0.471 | 0.056 | DNA gyrase inhibitor | 0.056 0.055 CID_154699820 | CID_154699820 | |
| 0.026 | 0.521 | 0.204 | Cell adhesion inhibitor | 0.204 0.024 CID_154699820 | CID_154699820 | |
| 0.068 | 0.679 | 0.339 | Interleukin 2 agonist | 0.339 0.051 CID_154699820 | CID_154699820 | |
| 0.008 | 0.781 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.021 CID_154699820 | CID_154699820 | |
| 0.006 | 0.815 | 0.131 | Anticoagulant | 0.131 0.1 CID_154699820 | CID_154699820 | |
| 0.013 | 0.861 | 0.252 | Immunomodulator | 0.252 0.113 CID_154699820 | CID_154699820 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |